VYGR Form 144 filing for 5,843-share planned sale
Rhea-AI Filing Summary
Voyager Therapeutics (VYGR) filed a Form 144 notice for a proposed sale of 5,843 common shares. The shares carry an aggregate market value of $27,936.55 and are slated for sale through Fidelity Brokerage Services LLC on or about 10/03/2025 on the NASDAQ.
The securities were acquired on 10/01/2025 via restricted stock vesting from the issuer as compensation. This is a routine compliance notice that permits the holder to sell these shares under Rule 144, subject to applicable volume and manner-of-sale conditions.
Positive
- None.
Negative
- None.
FAQ
What did VYGR disclose in this Form 144?
When is the approximate sale date for the VYGR shares?
How were the VYGR shares to be sold acquired?
How many VYGR shares are involved and what is the stated value?
Which broker is handling the proposed VYGR share sale?
On which exchange are the VYGR shares planned to be sold?